Valspring Capital

Valspring Capital is a Boston-based growth equity firm founded in 2022 by the former healthcare investment team of Bain Capital Ventures, dedicated to accelerating the future of healthcare with deep sector expertise and a proven track record. Beyond capital, Valspring takes an active, hands-on approach to portfolio oversight — including monitoring agreements and board engagement — leveraging deep healthcare relationships, commercial execution support, and disciplined follow-on capital and exit planning. The firm invests in growth-stage healthcare companies past product-market fit, focusing on healthcare IT, technology-enabled services, and healthcare services. Notable investments include Small Door Veterinary, Koala Health, Phoenix, Cardamom, Pediatrica Health Group, Verana Health, and Covetrus. Valspring closed its debut fund, Valspring Capital Fund I, at $255 million in January 2025, surpassing its target, and reports roughly $337 million in assets under management. It typically invests at the Series B stage, seeking companies bringing meaningful, lasting innovation to established healthcare subsectors.